AstraZeneca plc (AZN) Given "Buy" Rating at Deutsche Bank AG


's stock had its "buy" rating reiterated by equities research analysts at Deutsche Bank AG in a research note issued on Tuesday. They presently have a GBX 5,500 price objective on the biopharmaceutical company's stock.



from Biotech News